Europium-labeled anti-c-myc antibody, for capturing c-myc-tagged proteins in LANCE® TR-FRET assays.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Protein-Protein Interaction |
Europium-labeled anti-c-myc antibody, for capturing c-myc-tagged proteins in LANCE® TR-FRET assays.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
LANCE® Eu-labeled anti-c-myc antibodies are purified mouse IgG1 monoclonal antibodies, which recognize the epitope sequence (EQKLISEEDL) derived from the human c-myc protein. These monoclonal antibodies against the c-myc epitope do not cross react with other cellular proteins.
LANCE® (Lanthanide chelate excite) and LANCE® Ultra are our TR-FRET (time-resolved fluorescence resonance energy transfer), homogeneous (no wash) technologies. One molecule of interest is labeled with a donor fluorophore (a LANCE Europium chelate) and the second molecule is labeled with an acceptor fluorophore [ULight™ dye, allophycocyanin (APC), etc.]. Upon excitation at 320 or 340 nm, energy can be transferred from the donor Europium chelate to the acceptor fluorophore if sufficiently close for FRET (~10 nm). This results in the emission of light at 665 nm (for ULight dye and APC).
Application |
Protein-Protein Interaction
|
---|---|
Automation Compatible |
Yes
|
Brand |
LANCE Ultra
|
Conjugates |
Anti-c-Myc
|
Detection Modality |
LANCE
|
Fluorophore |
Eu-W1024
|
Product Group |
Antibody
|
Shipping Conditions |
Shipped in Dry Ice
|
Target Class |
Binding Assay
|
Technology |
TR-FRET
|
Unit Size |
1 mg
|
Are you looking for resources, click on the resource type to explore further.
We are here to answer your questions.